About this event

• Event lasts 12 hours

Schedule:

Practical workshops:

• ECG in action
• The heart in the emergency

Ischemic Heart Disease:

• Coronary anatomy by multislice computed tomography, from risk stratification to current evidence
• How long should we prescribe dual antiplatelet therapy in light of the most recent clinical trial results?
• Gender disparities in acute coronary syndromes: a comprehensive analysis of management, treatment, and prognosis

GSK Biopharma Symposium: Vaccines and cardiovascular diseases: new horizons in prevention”

INAUGURAL CONFERENCE: “Subclinical Metabolic and Cardiovascular Damage: Detecting and Preventing Invisible Risk”

Cardiometabolism I:

• Accelerated vascular aging as a marker of damage throughout life
• Vital connections: the cardio-reno-metabolic axis
• Should all hypertensive patients receive statins?

Cardiometabolism II:

• Personalized Physical Activity Programs: Differentiated Rehabilitation according to Cardiovascular Risk Factors
• We must consider every patient with high-risk DM or we must stratify the risk
• Every patient with Diabetes Mellitus should receive iSGLT2

Cardio obstetrics:

• “Hypertension in Pregnancy: How to Follow Up and When and How to Medicate”
• Women of childbearing age and antihypertensive medication: what should we take into account?
• Hypertension in Pregnancy: Role of Statins

Cardiovascular risk:

• How to assess cardiovascular risk: scores, serology, images?
• Lipoprotein (a) a shadow behind the risk
• Should we stratify risk the same for men and women?

Heart Failure :

• Comprehensive Strategies from Prevention to Treatment
• The Essentials of Echocardiography in Heart Failure. What the Clinician Should Look For
• Update on the treatment of heart failure with preserved ejection fraction 2024

CLOSING CONFERENCE: Treatment of Chronic Heart Failure: from evolution to revolution.

Organized by